These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19429421)

  • 1. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells.
    Chittasupho C; Xie SX; Baoum A; Yakovleva T; Siahaan TJ; Berkland CJ
    Eur J Pharm Sci; 2009 May; 37(2):141-50. PubMed ID: 19429421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.
    Zhang N; Chittasupho C; Duangrat C; Siahaan TJ; Berkland C
    Bioconjug Chem; 2008 Jan; 19(1):145-52. PubMed ID: 17997512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1.
    Fakhari A; Baoum A; Siahaan TJ; Le KB; Berkland C
    J Pharm Sci; 2011 Mar; 100(3):1045-56. PubMed ID: 20922813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles.
    Chittasupho C; Lirdprapamongkol K; Kewsuwan P; Sarisuta N
    Eur J Pharm Biopharm; 2014 Oct; 88(2):529-38. PubMed ID: 25119723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of LFA-1 Peptide-Methotrexate Conjugates in Modulating Endothelial Cell Inflammation and Cytokine Regulation.
    Yusuf-Makagiansar H; Yakovleva TV; Weldele M; Mahadik R; Siahaan TJ
    Med Res Arch; 2023 Feb; 11(2):. PubMed ID: 37063234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
    Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM
    Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na
    Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
    Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 alpha produced by human T-cell leukaemia virus type I-infected T cells induces intercellular adhesion molecule-1 expression on lung epithelial cells.
    Nakayama Y; Ishikawa C; Tamaki K; Senba M; Fujita J; Mori N
    J Med Microbiol; 2011 Dec; 60(Pt 12):1750-1761. PubMed ID: 21816944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The numbers of leukocyte subsets in lung sections differ between intercellular adhesion molecule-1-/-, lymphocyte function-associated antigen-1-/- mice and intercellular adhesion molecule-1-/- mice after aerosol exposure to Haemophilus influenzae type-b.
    Sinikovic B; Larbig M; Hedrich HJ; Pabst R; Tschernig T
    Virchows Arch; 2001 Apr; 438(4):362-9. PubMed ID: 11355170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
    Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
    J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
    Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
    J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
    J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
    Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
    Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of binding and internalization of ICAM-1-derived cyclic peptides by LFA-1 on the surface of T cells: a potential method for targeted drug delivery.
    Anderson ME; Siahaan TJ
    Pharm Res; 2003 Oct; 20(10):1523-32. PubMed ID: 14620502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined delivery of angiopoietin-1 gene and simvastatin mediated by anti-intercellular adhesion molecule-1 antibody-conjugated ternary nanoparticles for acute lung injury therapy.
    Jiang S; Li S; Hu J; Xu X; Wang X; Kang X; Qi J; Lu X; Wu J; Du Y; Xiao Y
    Nanomedicine; 2019 Jan; 15(1):25-36. PubMed ID: 30193816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: a potential ligand for drug targeting to ICAM-1-expressing cells.
    Yusuf-Makagiansar H; Siahaan TJ
    Pharm Res; 2001 Mar; 18(3):329-35. PubMed ID: 11442273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors.
    Anderson ME; Siahaan TJ
    Peptides; 2003 Mar; 24(3):487-501. PubMed ID: 12732350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.